Portfolio company Perfuze received FDA clearance for Millipede88, the first super-bore aspiration catheter cleared for standalone direct aspiration.
Perfuze is a commercial-stage neurovascular medical device company developing breakthrough technologies to improve outcomes for patients suffering from acute ischemic stroke
Perfuze is a commercial-stage neurovascular medical device company developing breakthrough technologies to improve outcomes for patients suffering from acute ischemic stroke. Our proprietary platform is designed to rapidly and completely remove clots, restoring blood flow to the brain and giving patients the best possible chance at recovery.